KRMD Quote, Financials, Valuation and Earnings

Retractable Technologies has a net margin of -12.1% compared to KORU Medical Systems's net margin of -126.59%. KORU Medical Systems's return on equity of -29.85% beat Retractable Technologies's return on equity of -26.39%.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 51.1%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that KORU Medical Systems has higher upside potential than Retractable Technologies, analysts believe KORU Medical Systems is more attractive than Retractable Technologies.

KORU Medical Systems has a beta of 0.520, which suggesting that the stock is 47.963% less volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.357, suggesting its more volatile than the S&P 500 by 35.696%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems pays -- of its earnings as a dividend. Retractable Technologies pays out -1.94% of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $9.6M, which are larger than Retractable Technologies quarterly revenues of $8.3M. KORU Medical Systems's net income of -$1.2M is higher than Retractable Technologies's net income of -$10.5M. Notably, KORU Medical Systems's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.76x versus 0.57x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX has a net margin of -12.1% compared to KORU Medical Systems's net margin of -2201.34%. KORU Medical Systems's return on equity of -29.85% beat VolitionRX's return on equity of --.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 51.1%. On the other hand VolitionRX has an analysts' consensus of $2.93 which suggests that it could grow by 282.86%. Given that VolitionRX has higher upside potential than KORU Medical Systems, analysts believe VolitionRX is more attractive than KORU Medical Systems.

KORU Medical Systems has a beta of 0.520, which suggesting that the stock is 47.963% less volatile than S&P 500. In comparison VolitionRX has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.798%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $9.6M, which are larger than VolitionRX quarterly revenues of $246.4K. KORU Medical Systems's net income of -$1.2M is higher than VolitionRX's net income of -$5.4M. Notably, KORU Medical Systems's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.76x versus 52.93x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -12.1% compared to KORU Medical Systems's net margin of -2828.67%. KORU Medical Systems's return on equity of -29.85% beat Catheter Precision's return on equity of -137.84%.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 51.1%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 761.7%. Given that Catheter Precision has higher upside potential than KORU Medical Systems, analysts believe Catheter Precision is more attractive than KORU Medical Systems.

KORU Medical Systems has a beta of 0.520, which suggesting that the stock is 47.963% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.724, suggesting its less volatile than the S&P 500 by 172.434%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $9.6M, which are larger than Catheter Precision quarterly revenues of $143K. KORU Medical Systems's net income of -$1.2M is higher than Catheter Precision's net income of -$4M. Notably, KORU Medical Systems's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.76x versus 2.67x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -12.1% compared to KORU Medical Systems's net margin of 0.18%. KORU Medical Systems's return on equity of -29.85% beat Xtant Medical Holdings's return on equity of -26.62%.

KORU Medical Systems has a consensus price target of $5.50, signalling upside risk potential of 51.1%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 144.76%. Given that Xtant Medical Holdings has higher upside potential than KORU Medical Systems, analysts believe Xtant Medical Holdings is more attractive than KORU Medical Systems.

KORU Medical Systems has a beta of 0.520, which suggesting that the stock is 47.963% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.139, suggesting its less volatile than the S&P 500 by 113.918%.

KORU Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KORU Medical Systems pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

KORU Medical Systems quarterly revenues are $9.6M, which are smaller than Xtant Medical Holdings quarterly revenues of $32.9M. KORU Medical Systems's net income of -$1.2M is lower than Xtant Medical Holdings's net income of $58K. Notably, KORU Medical Systems's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KORU Medical Systems is 4.76x versus 0.80x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.